DEC 09, 2019 4:14 PM PST

Astronauts help to advanced personalized medicine

WRITTEN BY: Tara Fernandez

Extreme temperatures and lethal levels of radiation are just some of the hazards faced by astronauts as they traverse the harsh conditions of space.

Additionally, space travelers on extended journeys are also subject to an accelerated aging phenomenon -- with effects like bone density loss, the hardening of blood vessels, and diminishing muscle mass.

Space health researchers like Dr. Annette Sobel, professor at the Texas Tech University of Health Sciences Center, are taking advantage of cutting edge diagnostic technologies to better understand and manage the physically demanding aspects of interplanetary voyages.

Dr. Sobel is part of a team developing personalized medical support to astronauts, and in doing so, propelling the possibility of early disease detection and precision care for patients on Earth.

For astronauts on long space missions, dropping into a clinic upon the first signs of a medical condition is not an option. In light of this, the astronauts’ health needs to be vigilantly monitored before take-off. Using genomic analysis techniques, space health teams are able to predict the risk of a particular disease developing in an individual and customize a preventative intervention plan accordingly. 

Dr. Sobel uses a variety of genomics, proteomics and metabolomics tools which allow her team to simulate disease progression based on a person’s genetic profile. Our genetic code holds a wealth of information: the number and combinations of genes speak to the chances of developing certain diseases, as well as the potential for experiencing side effects to drugs.

Here on earth, lessons learned from these innovations are already being translated to a better standard of care for many common illnesses. For instance, glaucoma is a leading cause of blindness in people over 60, caused by abnormally high pressure in the eyeball. Now, an increased understanding of the genetics of glaucoma progression, using the same techniques used to study astronauts, can empower clinicians and patients with more predictive power to halt disease progression earlier.

The next frontier for personalized medicine could mean that, like astronauts headed for galaxy explorations, we no longer have to wait for symptoms to develop before receiving clinical care.

Source: Mobi Health News

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
NOV 03, 2020
Clinical & Molecular DX
"Hello? It's Me, the Coronavirus."
NOV 03, 2020
"Hello? It's Me, the Coronavirus."
Researchers at MIT have discovered an unlikely way of discerning those with COVID-19 from healthy individuals — si ...
NOV 24, 2020
Cancer
Using Restfulness as a Metric for Measuring Sleep Quality and Cardiovascular Risk
NOV 24, 2020
Using Restfulness as a Metric for Measuring Sleep Quality and Cardiovascular Risk
Did you know sleeping is great? Apparently, getting a full eight hours every night can make you look fabulous and solve ...
DEC 14, 2020
Clinical & Molecular DX
STR Genotyping for Human Sample Identification
DEC 14, 2020
STR Genotyping for Human Sample Identification
Human sample identification is an essential element of many research projects employing human cells, tissues, or mixture ...
DEC 08, 2020
Genetics & Genomics
Advancing Genetic Sequencing with Better Computational Tools
DEC 08, 2020
Advancing Genetic Sequencing with Better Computational Tools
The many advances that have propelled the field of genetics forward have taken a tremendous amount of work in different ...
JAN 08, 2021
Neuroscience
Can We Identify Alzheimer's from Routine Eye Exams?
JAN 08, 2021
Can We Identify Alzheimer's from Routine Eye Exams?
As people with diabetes age, they are more likely than those without the condition to develop cognitive disorders such a ...
FEB 09, 2021
Clinical & Molecular DX
Make Tissues Transparent to Spot Hidden Tumors, Let Machines Do the Rest
FEB 09, 2021
Make Tissues Transparent to Spot Hidden Tumors, Let Machines Do the Rest
A clearly defined border differentiates benign tumors from malignant ones. Malignant tumors start to get fuzzy around th ...
Loading Comments...